Comparison of DEXA and hand radiograms method in diagnosis of bone mass density disturbances in cystic fibrosis patients
A. Minarowska, W. Tomalak, J. Zajac, L. Minarowski, J. Sienkiewicz, J. Olenski, M. Kaczmarski (Bialystok, Rabka, Zdroj, Warsaw, Poland)
Source: Annual Congress 2007 - Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Minarowska, W. Tomalak, J. Zajac, L. Minarowski, J. Sienkiewicz, J. Olenski, M. Kaczmarski (Bialystok, Rabka, Zdroj, Warsaw, Poland). Comparison of DEXA and hand radiograms method in diagnosis of bone mass density disturbances in cystic fibrosis patients. Eur Respir J 2007; 30: Suppl. 51, 2301
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Assessment of bone mass density and related parameters in patients with cystic fibrosis using hand radiograms Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006
Low-dose chest CT for bone mineral density in pediatric patients with cystic fibrosis Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020
Bone attenuation on chest computed tomography correlates with bone mineral density on densitometry in patients with emphysema and COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Bone mineral density in cystic fibrosis patients using low-dose chest computed tomography: a pilot study Source: Eur Respir J, 53 (6) 1900066; 10.1183/13993003.00066-2019 Year: 2019
Diagnosis and management of cystic fibrosis related low bone mineral density Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=150 Year: 2006
Evaluation of bone strength by quantitative ultrasound in children with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 339s Year: 2002
Changes in bone mineral density of lumbar spine during one year in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001
Changes in bone mineral density and fat-free mass following pulmonary rehabilitation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 607s Year: 2006
Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Airway inflammation and fat free mass measurements using dual energy X-ray absorptiometry in a population of chronic obstructive pulmonary disease patients Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008
Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Low bone mineral density in children with cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 388s Year: 2007
Bone density in adult patients with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 265s Year: 2002
Optical density of the bone and related parameters in adult patients with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 388s Year: 2007
Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis Source: Eur Respir J 2013; 42: 1545-1552 Year: 2013
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005
Changes in bone mineral density after lung volume reduction surgery for severe emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 607s Year: 2002
Ultrasonographic parameters of bone density in children with bronchial asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD Source: Eur Respir J 2002; 19: 626-631 Year: 2002
Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor Source: Eur Respir J 2005; 25: 54-61 Year: 2005